Single-cell transcriptomics of clinical grade adipose-derived regenerative cells reveals consistency between donors independent of gender and BMI
Adipose-derived regenerative cells (ADRCs) also referred to as the stromal vascular fraction, provide an ample source of stem cells with widespread regenerative therapeutic use. Being heterogenous in nature, possibly affecting the clinical outcome after stem cell treatment, the ADRC- donor, -BMI, and -gender may have a large impact on ADRC composition and quality but this remains largely unexplored. Herein, we provide a comprehensive single-cell RNA sequencing ADRC mapping across two cell trial intervention studies but found no gender- or BMI-related variations, except for a minor female increase in PI16/CD55-expressing stem cells. Indeed, ADRC heterogeneity was surprisingly minimal between donors. This provides important decision-making support on adipose stem cell donor selection for stem cell treatments, and suggest that donor, gender and BMI should be regarded as less influential.
Authors
- Jakob V. Nielsen (ORCID: https://orcid.org/0000-0003-4589-7299)
- Charlotte Harken Jensen (ORCID: https://orcid.org/0000-0001-9683-8761)
- Lars Lund (ORCID: https://orcid.org/0000-0003-0391-9568)
- Pratibha Dhumale (ORCID: https://orcid.org/0000-0002-8645-2301)
- Mads Gustaf Jørgensen (ORCID: https://orcid.org/0000-0002-8755-3446)
- Mark Burton (ORCID: https://orcid.org/0000-0002-3782-5933)
- Jens Ahm Sørensen (ORCID: https://orcid.org/0000-0003-4903-0094)
- Frederik Adam Bjerre (ORCID: https://orcid.org/0000-0001-6733-4599)
- Ditte Caroline Andersen (ORCID: https://orcid.org/0000-0003-4940-7912)
- Sabrina Toft Hansen
- Mads Thomassen (ORCID: https://orcid.org/0000-0003-0078-1217)
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1186/s13287-025-04234-4
- Citations
- 4
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Innovationsfonden
- Novo Nordisk
- Odense Universitetshospital
- Syddansk Universitet
- Novo Nordisk Fonden
- Klinisk Institut, Syddansk Universitet